Amyloid PET Changes During Lecanemab Treatment in Patients With and Without Amyloid-related Imaging Abnormalities
- 20 October 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 51 (12) , 1099-1101
Abstract
Lecanemab reduces cerebral amyloid-β burden in Alzheimer disease, but whether amyloid-related imaging abnormalities (ARIA) are associated with greater amyloid clearance remains unclear. We report 3 patients with comparable clinical backgrounds and similar baseline cognitive performance who underwent amyloid-β PET before and after lecanemab treatment. Quantitative analysis using Centiloid showed a greater reduction in amyloid burden in the patient who developed ARIA than in the 2 patients without ARIA. These observations suggest ARIA may be associated with more pronounced treatment-related amyloid clearance, warranting further investigation in larger cohorts.Keywords
This publication has 8 references indexed in Scilit:
- Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s immunotherapy: a framework and challenges for global surveillance strategiesJournal of Neurology, Neurosurgery & Psychiatry, 2026
- Anti-Amyloid Monoclonal Antibodies for Alzheimer’s Disease: Evidence, ARIA Risk, and Precision Patient SelectionJournal of Personalized Medicine, 2025
- Myeloid-mediated cerebral amyloid vasculitis and the potential role of the immune response in brain atrophyJournal of Clinical Investigation, 2025
- Vascular alterations in PDAPP mice after anti‐Aβ immunotherapy: Implications for amyloid‐related imaging abnormalitiesAlzheimer's & Dementia, 2013
- A Single Ascending Dose Study of Bapineuzumab in Patients With Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2010
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseNeurology, 2009
- A -related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathyBrain, 2005
- Clinical manifestations of cerebral amyloid angiopathy–related inflammationAnnals of Neurology, 2004